Clinical trial · Observational
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian
NCT01538498CI-TRIAL-00009851completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
* Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively * Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Devleopment for the peritoneal carcinomatosis index (PCI)
- timeFrame
- 55 months
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: 1. Preoperative clinical diagnosis of ovarian cancer, tubal cancer, and primary peritoneal carcinoma (all stage) 2. Available preoperative image study (CT and/or MRI and/or PET) 3. Patients who gave a written informed consent 4. Patients must be surgical candidate considering medical and psychological condition Exclusion Criteria: * Patients who refuse to participate or want to withdraw at anytime.
References
Publications (0)
Data not yet available
No reference posted for this study.